Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer. 2003

Tatsuya Toyama, and Hirotaka Iwase, and Hiroko Yamashita, and Yasuo Hara, and Yoko Omoto, and Hiroshi Sugiura, and Zhenhuan Zhang, and Yoshitaka Fujii
Department of Surgery II, Nagoya City University Medical School, Nagoya 467-8601, Japan. toyamat-ncu@umin.ac.jp

Syk is a non-receptor type of protein-tyrosine kinase that is widely expressed in hematopoietic cells. Syk expression has been reported in breast tissue. However, the function of Syk in breast tissue remains unclear. In 25 (28%) of the 90 paired samples of human breast cancer and the matched, adjacent non-cancerous tissues examined here, reduced mRNA expression of Syk in the breast cancer tissues was observed by real-time quantitative reverse transcription-polymerase chain reaction. Eight (32%) of the 25 cases showing reduced Syk mRNA expression demonstrated distant metastasis of breast cancer, while only 4 (6%) of the 65 cases who did not show reduced Syk expression had distant metastasis. Kaplan-Meier curves demonstrated that patients with reduced Syk expression were at significantly increased risk for distant metastasis (P=0.0003). Our data suggest that reduced Syk expression in breast cancers is associated with distant metastasis and poor prognosis; therefore, Syk is considered to be a potential tumor suppressor and anti-metastasis gene in human breast cancer.

UI MeSH Term Description Entries
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004792 Enzyme Precursors Physiologically inactive substances that can be converted to active enzymes. Enzyme Precursor,Proenzyme,Proenzymes,Zymogen,Zymogens,Precursor, Enzyme,Precursors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072377 Syk Kinase An SH2 domain-containing non-receptor tyrosine kinase that regulates signal transduction downstream of a variety of receptors including B-CELL ANTIGEN RECEPTORS. It functions in both INNATE IMMUNITY and ADAPTIVE IMMUNITY and also mediates signaling in CELL ADHESION; OSTEOGENESIS; PLATELET ACTIVATION; and vascular development. SYK Tyrosine Kinase,Spleen Tyrosine Kinase,Kinase, SYK Tyrosine,Kinase, Spleen Tyrosine,Kinase, Syk,Tyrosine Kinase, SYK,Tyrosine Kinase, Spleen
D047908 Intracellular Signaling Peptides and Proteins Proteins and peptides that are involved in SIGNAL TRANSDUCTION within the cell. Included here are peptides and proteins that regulate the activity of TRANSCRIPTION FACTORS and cellular processes in response to signals from CELL SURFACE RECEPTORS. Intracellular signaling peptide and proteins may be part of an enzymatic signaling cascade or act through binding to and modifying the action of other signaling factors. Intracellular Signaling Peptides,Intracellular Signaling Proteins,Peptides, Intracellular Signaling,Proteins, Intracellular Signaling,Signaling Peptides, Intracellular,Signaling Proteins, Intracellular

Related Publications

Tatsuya Toyama, and Hirotaka Iwase, and Hiroko Yamashita, and Yasuo Hara, and Yoko Omoto, and Hiroshi Sugiura, and Zhenhuan Zhang, and Yoshitaka Fujii
July 2012, Oncology letters,
Tatsuya Toyama, and Hirotaka Iwase, and Hiroko Yamashita, and Yasuo Hara, and Yoko Omoto, and Hiroshi Sugiura, and Zhenhuan Zhang, and Yoshitaka Fujii
June 2017, Medicine,
Tatsuya Toyama, and Hirotaka Iwase, and Hiroko Yamashita, and Yasuo Hara, and Yoko Omoto, and Hiroshi Sugiura, and Zhenhuan Zhang, and Yoshitaka Fujii
September 2014, Hepato-gastroenterology,
Tatsuya Toyama, and Hirotaka Iwase, and Hiroko Yamashita, and Yasuo Hara, and Yoko Omoto, and Hiroshi Sugiura, and Zhenhuan Zhang, and Yoshitaka Fujii
June 2017, Wiener klinische Wochenschrift,
Tatsuya Toyama, and Hirotaka Iwase, and Hiroko Yamashita, and Yasuo Hara, and Yoko Omoto, and Hiroshi Sugiura, and Zhenhuan Zhang, and Yoshitaka Fujii
November 2018, Pathology, research and practice,
Tatsuya Toyama, and Hirotaka Iwase, and Hiroko Yamashita, and Yasuo Hara, and Yoko Omoto, and Hiroshi Sugiura, and Zhenhuan Zhang, and Yoshitaka Fujii
July 2022, Neoplasma,
Tatsuya Toyama, and Hirotaka Iwase, and Hiroko Yamashita, and Yasuo Hara, and Yoko Omoto, and Hiroshi Sugiura, and Zhenhuan Zhang, and Yoshitaka Fujii
June 2023, Clinical breast cancer,
Tatsuya Toyama, and Hirotaka Iwase, and Hiroko Yamashita, and Yasuo Hara, and Yoko Omoto, and Hiroshi Sugiura, and Zhenhuan Zhang, and Yoshitaka Fujii
November 2015, Virchows Archiv : an international journal of pathology,
Tatsuya Toyama, and Hirotaka Iwase, and Hiroko Yamashita, and Yasuo Hara, and Yoko Omoto, and Hiroshi Sugiura, and Zhenhuan Zhang, and Yoshitaka Fujii
April 2014, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Tatsuya Toyama, and Hirotaka Iwase, and Hiroko Yamashita, and Yasuo Hara, and Yoko Omoto, and Hiroshi Sugiura, and Zhenhuan Zhang, and Yoshitaka Fujii
June 2006, Cancer science,
Copied contents to your clipboard!